Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro
- 1 December 2014
- journal article
- Published by Elsevier in Immunobiology
- Vol. 219 (12) , 980-989
Abstract
No abstract availableKeywords
Funding Information
- Chinese 973 project (2012CB517702)
- National Natural Science Foundation of China (81021004, 81100497)
This publication has 51 references indexed in Scilit:
- Complement, interferon and lupusCurrent Opinion in Immunology, 2012
- Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markersLupus, 2011
- C1q Differentially Modulates Phagocytosis and Cytokine Responses during Ingestion of Apoptotic Cells by Human Monocytes, Macrophages, and Dendritic CellsThe Journal of Immunology, 2009
- Autoantibodies against Complement C1q Specifically Target C1q Bound on Early Apoptotic CellsThe Journal of Immunology, 2009
- Immune complex binding by immunocamouflaged [poly(ethylene glycol)‐grafted] erythrocytesAmerican Journal of Hematology, 2007
- Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosusArthritis & Rheumatism, 2006
- Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complementAnnals of the Rheumatic Diseases, 2006
- Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year PeriodMedicine, 2003
- C1q, Autoimmunity and ApoptosisImmunobiology, 2002
- Primate erythrocyte-immune complex-clearing mechanism.Journal of Clinical Investigation, 1983